Ebos Group Ltd (EBO) - Total Assets

Latest as of June 2025: AU$7.84 Billion AUD ≈ $5.55 Billion USD

Based on the latest financial reports, Ebos Group Ltd (EBO) holds total assets worth AU$7.84 Billion AUD (≈ $5.55 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EBO net assets for net asset value and shareholders' equity analysis.

Ebos Group Ltd - Total Assets Trend (1995–2025)

This chart illustrates how Ebos Group Ltd's total assets have evolved over time, based on quarterly financial data.

Ebos Group Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Ebos Group Ltd's total assets of AU$7.84 Billion consist of 42.4% current assets and 57.6% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 2.5%
Accounts Receivable AU$1.63 Billion 20.8%
Inventory AU$1.45 Billion 18.5%
Property, Plant & Equipment AU$0.00 0.0%
Intangible Assets AU$608.00 Million 7.8%
Goodwill AU$2.42 Billion 30.9%

Asset Composition Trend (1995–2025)

This chart illustrates how Ebos Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Ebos Group Ltd market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ebos Group Ltd's current assets represent 42.4% of total assets in 2025, a decrease from 89.6% in 1995.
  • Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 5.0% in 1995.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 37.0% of total assets, an increase from 0.0% in 1995.
  • Asset Diversification: The largest asset category is goodwill at 30.9% of total assets.

Ebos Group Ltd Competitors by Total Assets

Key competitors of Ebos Group Ltd based on total assets are shown below.

Company Country Total Assets
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Cyclopharm Ltd
AU:CYC
Australia AU$55.91 Million
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥233.15 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
China CN¥83.17 Billion
Jointown Pharmaceutical Group Co Ltd
SHG:600998
China CN¥112.28 Billion

Ebos Group Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.18 0.95 1.14
Quick Ratio 0.67 0.57 0.73
Cash Ratio 0.00 0.00 0.00
Working Capital AU$507.31 Million AU$-155.38 Million AU$269.98 Million

Ebos Group Ltd - Advanced Valuation Insights

This section examines the relationship between Ebos Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.65
Latest Market Cap to Assets Ratio 0.32
Asset Growth Rate (YoY) 6.4%
Total Assets AU$7.84 Billion
Market Capitalization $2.51 Billion USD

Valuation Analysis

Below Book Valuation: The market values Ebos Group Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Ebos Group Ltd's assets grew by 6.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Ebos Group Ltd (1995–2025)

The table below shows the annual total assets of Ebos Group Ltd from 1995 to 2025.

Year Total Assets Change
2025-06-30 AU$7.84 Billion
≈ $5.55 Billion
+6.35%
2024-06-30 AU$7.37 Billion
≈ $5.21 Billion
+5.19%
2023-06-30 AU$7.01 Billion
≈ $4.96 Billion
+0.85%
2022-06-30 AU$6.95 Billion
≈ $4.91 Billion
+63.67%
2021-06-30 AU$4.24 Billion
≈ $3.00 Billion
+5.82%
2020-06-30 AU$4.01 Billion
≈ $2.84 Billion
+19.70%
2019-06-30 AU$3.35 Billion
≈ $2.37 Billion
+2.67%
2018-06-30 AU$3.26 Billion
≈ $2.31 Billion
+1.80%
2017-06-30 AU$3.21 Billion
≈ $2.27 Billion
+0.40%
2016-06-30 AU$3.19 Billion
≈ $2.26 Billion
+25.21%
2015-06-30 AU$2.55 Billion
≈ $1.80 Billion
+10.43%
2014-06-30 AU$2.31 Billion
≈ $1.63 Billion
-8.79%
2013-06-30 AU$2.53 Billion
≈ $1.79 Billion
+284.76%
2012-06-30 AU$658.00 Million
≈ $465.58 Million
+22.23%
2011-06-30 AU$538.32 Million
≈ $380.89 Million
+3.85%
2010-06-30 AU$518.34 Million
≈ $366.76 Million
+3.70%
2009-06-30 AU$499.83 Million
≈ $353.66 Million
+2.81%
2008-06-30 AU$486.19 Million
≈ $344.01 Million
+254.30%
2007-06-30 AU$137.23 Million
≈ $97.10 Million
+1.85%
2006-06-30 AU$134.74 Million
≈ $95.33 Million
+13.11%
2005-06-30 AU$119.11 Million
≈ $84.28 Million
+28.72%
2004-06-30 AU$92.54 Million
≈ $65.48 Million
-0.09%
2003-06-30 AU$92.62 Million
≈ $65.53 Million
+2.47%
2002-06-30 AU$90.39 Million
≈ $63.96 Million
+49.76%
2001-06-30 AU$60.35 Million
≈ $42.70 Million
+71.56%
1999-06-30 AU$35.18 Million
≈ $24.89 Million
+19.20%
1998-06-30 AU$29.51 Million
≈ $20.88 Million
+13.27%
1997-06-30 AU$26.05 Million
≈ $18.44 Million
+87.93%
1996-06-30 AU$13.86 Million
≈ $9.81 Million
+10.01%
1995-06-30 AU$12.60 Million
≈ $8.92 Million
--

About Ebos Group Ltd

AU:EBO Australia Medical Distribution
Market Cap
$2.51 Billion
AU$3.55 Billion AUD
Market Cap Rank
#5473 Global
#128 in Australia
Share Price
AU$17.48
Change (1 day)
+0.34%
52-Week Range
AU$17.06 - AU$37.95
All Time High
AU$41.58
About

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligenc… Read more